C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
01/2003
01/02/2003	EP1268437A1 Inhibitors of protein kinases
01/02/2003	EP1268433A1 Cyclic lactams as inhibitors of a-beta-protein production
01/02/2003	EP1268429A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
01/02/2003	EP1268425A2 Carbamate caspase inhibitors and uses thereof
01/02/2003	EP1268422A1 Indoles for treating diseases that can be treated using thyroid hormones
01/02/2003	EP1268421A2 Phenyl-substituted indoles as histamine h3-receptor antagonists
01/02/2003	EP1268419A1 Pyrrolidine derivatives useful as bax inhibitors
01/02/2003	EP1268418A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
01/02/2003	EP1267819A2 Preparation containing quinoxaline derivatives
01/02/2003	EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
01/01/2003	CN1388129A Extraction process of chlorhematin as iron-replenishing agent
01/01/2003	CN1387846A Intraocular pressure reducing agent
12/2002
12/31/2002	US6500950 Benzylidenepyrazolones, their preparation and use
12/31/2002	US6500854 Chondrongenesis promotors and indolin-2-one derivatives
12/31/2002	US6500851 Antithrombotic agents
12/31/2002	US6500848 Pesticides
12/31/2002	US6500841 Inhibitors of farnesyl-protein transferase
12/31/2002	US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
12/31/2002	US6500821 Treat various forms of epilepsies and of states of anxiety and tension.
12/31/2002	CA2075586C Salicyloyl(thio)ether derivatives, their preparation and intermediates for ther preparation
12/27/2002	WO2002102978A2 Human growth hormone antagonists
12/27/2002	WO2002102793A2 Quinazolinediones as antibacterial agents
12/27/2002	WO2002102791A1 Pyrrolidine bicyclic compounds
12/27/2002	WO2002102790A1 N-formyl hydroxylamine compounds as inhibitors of pdf
12/27/2002	WO2002102783A1 Tyrosine kinase inhibitors
12/27/2002	WO2002102782A2 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
12/27/2002	WO2002102359A2 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
12/27/2002	WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
12/27/2002	WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002	WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002	WO2002092565A3 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
12/27/2002	WO2002074753A3 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
12/27/2002	CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002	CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002	CA2450724A1 Quinazoline and pyrido¬2,3-d\|pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002	CA2449977A1 Human growth hormone antagonists
12/27/2002	CA2449212A1 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
12/27/2002	CA2448526A1 N-formyl hydroxylamine compounds as inhibitors of pdf
12/27/2002	CA2446963A1 Quinazolinediones as antibacterial agents
12/27/2002	CA2446931A1 Pyrrolidine bicyclic compounds
12/26/2002	US20020198255 2,4-substituted pyrrolidine derivatives-CCR-3 receptor antagonists
12/26/2002	US20020198254 Bactericides, fungicides and parasticides
12/26/2002	US20020198237 2,5-substituted imidazole compounds useful as histamine H3 receptor mediators
12/26/2002	US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions
12/26/2002	US20020198213 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/26/2002	US20020198210 Alpha-2-adrenergic agonist/fatty acid compositions
12/26/2002	US20020198206 Such as 1-Cyclohexyl-4-(4-fluorophenyl)-5-((2-phenylamino)pyrimidin-4-yl)imidazole; for use as cytokine inhibitors
12/26/2002	US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002	US20020198197 Metabotropic glutamate receptor agonist for treatment or prevention of acute and/or chronic neurological disorders
12/26/2002	US20020198194 Neuropeptide Y (NPY) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
12/26/2002	US20020198156 Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor
12/25/2002	CN1387531A Pyrazolo [4,3-d] pyrimidine derivs.
12/25/2002	CN1387529A N-substd. carbamoyloxyalkyl-azolium derivs.
12/25/2002	CN1387528A Heterocyclic substd, pyrazolones
12/25/2002	CN1387516A Substd. 5-benzyl-2,4-diaminopyrimidines
12/25/2002	CN1387087A Color coupler for forming dye, silver halide photosensitive material and azomethine dyes compounds
12/25/2002	CN1097052C Process for production of amidinoindole derivs, and salts thereof
12/25/2002	CN1097050C Substd 2,4-imidazolidinedione compounds and pharmaceutical active ingredients
12/25/2002	CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides
12/24/2002	US6498252 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/24/2002	US6498251 Tetrahydrobenzindole derivatives
12/24/2002	US6498177 Alpha 2 adrenergic receptor agonist; analgesic, sedative and anaesthetic agents
12/24/2002	US6498176 Inhibiting tumor growth via inhibition of tumor-related angiogenesis
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6498170 4-((2s)-3-(1-(4-butoxy-benzenesulfonyl)-azetidin-3-ylamino)-2 -hydroxy- propoxy)-phenol for example; hypoglycemic agent; increasing lean meat to fat ratio in mammals
12/24/2002	US6498169 Cyclic amine compounds and pharmaceutical composition containing the same
12/24/2002	US6498168 Muscarinic antagonists
12/24/2002	US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002	US6498159 Such as 4-((3-chloro-4-methoxybenzyl)amino)-1-((4-hydroxy-4 -hydroxymethyl)piperidino)-6-phthalazine carbonitrile
12/24/2002	US6498158 Il-5 inhibiting 6-azauracil derivatives
12/24/2002	US6498004 Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
12/24/2002	US6497886 1,3-bis-(N-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/24/2002	CA2054339C 3-amidoindolyl derivatives
12/19/2002	WO2002101073A2 Aryl-benzimidazole compounds having antiinfective activity
12/19/2002	WO2002101007A2 Antipathogenic benzamide compounds
12/19/2002	WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002	WO2002100853A1 Pyrazole derivatives as hiv reverse transcriptase inhibitors
12/19/2002	WO2002100852A1 Benzothiophene compounds having antiinfective activity
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100838A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002	WO2002100832A1 Isoquinoline compounds having antiinfective activity
12/19/2002	WO2002100486A1 Method and apparatus for treating uterine myoma
12/19/2002	WO2002100368A1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye
12/19/2002	WO2002100365A1 Use of dicationic compounds for dyeing human keratinous fibres and compositions containing same
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002085853A3 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/19/2002	WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002	WO2002074777A3 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity
12/19/2002	WO2002063957A3 Selective substituted aryl ketone and safener based herbicides
12/19/2002	US20020193595 Agonists of the melanocortin-4 receptor ("MC-4r"); useful treating obesity and type 2 diabetes
12/19/2002	US20020193420 Neurotrophic, low molecular weight, small molecule heterocyclic ketone or thioester compounds are nonimmunosuppressive, has an affinity for FKBP type immunophilins
12/19/2002	US20020193415 Phenylindoles for the treatment of HIV
12/19/2002	US20020193411 Pesticidal 1-polyarylpyrazoles
12/19/2002	US20020193390 Pharmaceutical compositions containing an N-(substituted glycyl)-2- cyanopyrrolidine and at least one other antidiabetic agent and their use in inhibiting dipeptidyl peptidase-IV
12/19/2002	US20020193382 Sulfonamide derivatives, their production and use
12/19/2002	US20020193377 Quinazolines as MMP-13 inhibitors

1 ... 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 ... 626